Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Multicenter inception cohort of enthesitis-related arthritis: variation in disease characteristics and treatment approaches

Fig. 2

Medications prescribed based on clinical phenotype. Medications prescribed across sites for (a) sacroiliitis (magnetic resonance imaging [MRI]-defined), (b) peripheral arthritis, and (c) enthesitis only. Children were considered as having one of the following three mutually exclusive phenotypes with the following hierarchy: (1) sacroiliitis (MRI-defined), (2) peripheral arthritis, and (3) enthesitis. Biologic medications included tumor necrosis factor-α inhibitors (adalimumab, etanercept, infliximab). Sacroiliitis data were not available for site 4. No children from site 2 or 3 were diagnosed with isolated enthesitis, and of those with enthesitis, none were prescribed IA injections or glucocorticoids. DMARD Disease-modifying antirheumatic drug, Glucocorticoids Oral glucocorticoids, IA Intra-articular glucocorticoid injection, NSAIDs Nonsteroidal anti-inflammatory drugs

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us